Cargando…
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study
BACKGROUND: The bidirectional signaling between the gut microbiota and the brain, known as the gut-brain axis, is being heavily explored in current neuropsychiatric research. Analyses of the human gut microbiota have shown considerable individual variability in bacterial content, which is hypothesiz...
Autores principales: | Chinna Meyyappan, Arthi, Milev, Roumen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303825/ https://www.ncbi.nlm.nih.gov/pubmed/32495743 http://dx.doi.org/10.2196/17223 |
Ejemplares similares
-
Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2022) -
The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2021) -
Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2020) -
Systematic review of probiotics as an adjuvant treatment for psychiatric disorders
por: Forth, Evan, et al.
Publicado: (2023) -
The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study
por: Wallace, Caroline J. K., et al.
Publicado: (2021)